By Russell Pearlman, originally published in issue 35 of Briefings Magazine, and posted on KornFerry.com on May 15, 2018. Kurt Graves had just heard from multiple investors in Intarcia Therapeutics, the pharmaceutical firm he runs, asking him a single question: Why...
Following the launch of The Global Talent Crunch, Korn Ferry is pleased to share The Salary Surge. This latest report in our future of work series outlines the potential costs that organizations may need to pay to secure skilled talent amidst severe global skilled...